Quick Answer
ClearPoint Neuro, Inc. reported Net Income Loss of -$25.54 million for the year ending 2025.
- ClearPoint Neuro, Inc. showed a decrease of -35.0% in Net Income Loss from 2024 to 2025.
- This data is from ClearPoint Neuro, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), ClearPoint Neuro, Inc.'s Net Income Loss has declined by 170.1%.
- Historical annual values: Fiscal year 2025: -$25.54 million | Fiscal year 2024: -$18.91 million | Fiscal year 2023: -$22.09 million | Fiscal year 2022: -$16.44 million | Fiscal year 2021: -$14.41 million | Fiscal year 2020: -$6.78 million | Fiscal year 2019: -$5.54 million | Fiscal year 2018: -$6.16 million | Fiscal year 2017: -$7.17 million | Fiscal year 2016: -$8.07 million | Fiscal year 2015: -$8.45 million | Fiscal year 2014: -$4.52 million | Fiscal year 2013: -$7.09 million | Fiscal year 2012: -$5.88 million | Fiscal year 2011: -$8.31 million | Fiscal year 2010: -$9.45 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: